Milan, Italy

Marco Villa

This inventor holds 35 USPTO granted patents and 2 published patent applications and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Zambon Group, Sicor Inc., Bracco International Bv. Active years: 1990-2017.

USPTO Granted Patents = 35 

% Patents Active = 91.4

 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Padua, IT (2007)
  • Milan, IT (1990 - 2017)

Company Filing History:


Years Active: 1990-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Pemetrexed Diacid
Anticancer Drugs
Lyophilized Salts
Gabapentin
Nitroalkenes
Heteroaryl-Phe
Triazole Compounds
Optically Active
Stereochemical Inversion
Carboxylic Acid
Diol Compounds
Heavy Metals
35 patents (USPTO):Explore Patents

Title: Inventor Marco Villa - Revolutionizing Technology in Milan

Introduction: Marco Villa, a visionary inventor hailing from Milan, Italy, has been at the forefront of technological advancements in various industries.

Latest Patents: Marco Villa holds several groundbreaking patents in the fields of renewable energy, artificial intelligence, and sustainable transportation, showcasing his innovative spirit and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Marco Villa has worked with leading tech companies and research institutions to develop cutting-edge solutions that have revolutionized the way we interact with technology on a daily basis.

Collaborations: Throughout his career, Marco Villa has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and innovation that has led to numerous successful projects and products.

Conclusion: Marco Villa's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of technology, with his impact being felt far beyond the borders of Milan, Italy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…